IMMUTRIN LTD
Company number 12217886 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£3,729,508
Balance sheet as at 2025-08-31
What it does
The principle activity of the Company continues to be that of research and development of biotechnology.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-09-20
- Employees
- 8 (2025 accounts · was 6 in 2024)
- Registered office
- Cambridge Innovation Capital, 22 Station Road, Cambridge, United Kingdom, CB1 2JD
- Postcode
- CB1 2JD
- Capital
- 720 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-08-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-09-19
- Next due by
- 2026-10-03
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 6 current · 2 resigned
Group structure
Controlled by CAMBRIDGE INNOVATION CAPITAL LIMITED — since 2022-03-31
From persons-with-significant-control filings on the public register.
Among its peers
Top 25%
by shareholders' funds, of 235 similar companies in CB
Trading since 2019.
Competitors Cambridge
This company ranks 33 among research and experimental development on biotechnology in Cambridge.
The class of 2019
39%
of the 500 companies in this sector incorporated in 2019 are still active today; 57% have since been dissolved.
A fact about the year, not a forecast for this company.